Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Quinoxaline derivatives as tyrosine kinase activity inhibitors

Quinoxaline derivatives as tyrosine kinase activity inhibitors

US Patent 8193189 · Granted Jun 5, 2012

Estimated economic value: $8,745,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted 2,4-dioxotetrahydropyrimidines as intermediates in the synthesis of 2025
Compounds and compositions for inhibiting the activity of HIF2-alpha and their m2025
NLRP3 inflammasome inhibitors2024
Biaryl derivatives as YAP/TAZ-TEAD protein-protein interaction inhibitors2024
Bicyclic compounds and their uses2024
Pyrazolyl derivatives useful as anti-cancer agents2023
Substituted pyrrolo[2,3-d]pyrimidines as Bruton's Tyrosine Kinase inhibitors2023
3-hydroxy-N-(3-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl)pyrrolidine-1-carboxamide2023
NLRP3 inflammasome inhibitors2022
NLRP3 inflammasome inhibitors2021
Aza-indazole compounds for use in tendon and/or ligament injuries2021
Formylated N-heterocyclic derivatives as FGFR4 inhibitors2020